Dentium Co Ltd
KRX:145720
Dentium Co Ltd
KRX:145720
Price:
51 100
KRW
2.71%
Market Cap:
₩440.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Dentium Co Ltd
KRX:145720
|
KR |
|
Kalnorth Gold Mines Ltd
ASX:KGM
|
AU |
Relative Value
The Relative Value of one
Dentium Co Ltd
stock under the Base Case scenario is
87 682.01
KRW.
Compared to the current market price of 51 100 KRW,
Dentium Co Ltd
is
Undervalued by 42%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
87 682.01
KRW
Undervaluation 42%
Multiples Across Competitors
Competitors Multiples
Dentium Co Ltd Competitors
Dentium Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Dentium Co Ltd
KRX:145720
|
440.7B KRW | 1.2 | 10.5 | 6 | 8.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 4.1 | 27.9 | 16 | 22 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.9B USD | 16.6 | 58.4 | 44.3 | 54.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 5 | 38.6 | 19.8 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.7 | 11.1 | 15.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.8 | 24.6 | 27 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.9B USD | 10.7 | 43.3 | 30.7 | 34 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
